Fusion Polypeptide Comprising S-antigen Repeat Units
The present invention relates to a fusion polypeptide comprising a) at least one fragment of the Plasmodium falciparum S-antigen or a variant thereof, wherein the fragment comprises one or a plurality of Plasmodium falciparum S-antigen repeat unit(s) or variant(s) thereof and b) at least one antigen different from the S-antigen. The present invention also relates to a pharmaceutical composition comprising that fusion polypeptide as well as to the use thereof for the treatment or prevention of an autoimmune disease, an allergic reaction, a transplantation-related complication, e.g. graft rejection or 'graft vs. host disease', and another inflammatory disease and a method for treatment or prevention of said conditions.
Patents:US 2,009,047,009
Inventor(s):
FALK KIRSTEN [DE]; ROETZSCHKE OLAF [DE]; LUCIUS RICHARD [DE]
Type of Offer:
Sale
« More Pharmaceutical Patents